Pharmaceutical & Biopharmaceutical Development Services
EAG brings unparalleled expertise to the development and commercialization of small molecule drugs, biopharmaceuticals, antibody-drug conjugates (ADCs), drug-device combination…
EAG brings unparalleled expertise to the development and commercialization of small molecule drugs, biopharmaceuticals, antibody-drug conjugates (ADCs), drug-device combination products and other therapies. From designing IND-enabling studies to delivering full CMC analytical and QC support, we join your R&D team as a true partner. EAG scientists take time to understand both your commercial goals and the unique characteristics of your compound. We provide expert guidance to balance regulatory expectations with expediency and cost, and approach technical challenges with flexibility and resolve.
When it comes to understanding the physical structure, chemical properties and composition of materials, no scientific services company offers the breadth of experience, diversity…
When it comes to understanding the physical structure, chemical properties and composition of materials, no scientific services company offers the breadth of experience, diversity of analytical techniques or technical ingenuity of EAG. From polymers to composites, thin films to superalloys—we know how to leverage materials sciences to gain a competitive edge. At EAG, we don’t just perform testing, we drive commercial success—through thoughtfully designed investigations, technically superior analyses and expert interpretation of data.
Having helped develop the test methods that shape current regulatory guidelines, EAG chemists, biologists and toxicologists have evaluated the environmental impact of thousands of…
Having helped develop the test methods that shape current regulatory guidelines, EAG chemists, biologists and toxicologists have evaluated the environmental impact of thousands of active ingredients and formulations—from pesticides and pharmaceuticals to industrial chemicals and consumer products. Whether you are exploring “what if” scenarios, registering a new active ingredient or formulation, responding to a data call-in or seeking to understand the latest guidance, turn to EAG for technical excellence, sound advice, GLP-compliant study execution and expert interpretation.
Whether connecting the internet of things, guiding surgical lasers or powering the latest smart phone, integrated circuits and microelectronics touch nearly every aspect of human…
Whether connecting the internet of things, guiding surgical lasers or powering the latest smart phone, integrated circuits and microelectronics touch nearly every aspect of human life. In the world of technology, innovation and continuous improvement are imperatives—and being able to quickly and reliably test, debug, diagnose failures and take corrective action can make the difference between a doomed product launch and building a successful global brand. EAG offers you the world’s largest and most diverse collection of specialized analytical instrumentation, capacity to perform a variety of microelectronic tests in parallel, and the multi-disciplinary expertise required to draw true insight from data.
No contract service provider has more experience performing custom synthesis and producing isotopically labeled compounds to support product development in life science, chemical…
No contract service provider has more experience performing custom synthesis and producing isotopically labeled compounds to support product development in life science, chemical and related industries than we do. From 14C and 3H radiolabeled clinical trial materials synthesized under cGMP, to stable-labeled active ingredients for metabolism and environmental fate/effects testing, turn to EAG. We have extensive experience with multi-step and other complex synthesis projects, and our comprehensive, in-house analytical services ensure quick turnaround of purity and structural confirmation.
EAG combines biotechnology and protein characterization expertise with more than 50 years' experience analyzing chemical compounds in plant and environmental matrices to address…
EAG combines biotechnology and protein characterization expertise with more than 50 years’ experience analyzing chemical compounds in plant and environmental matrices to address the growing needs of the biotechnology crop industry. We offer a wide range of techniques required to fully characterize the event insertion and expressed proteins, as well as the various studies required to confirm the food, feed and environmental safety of products that represent the trait. From early-stage protein confirmation to GLP-compliant EDSP and allergenicity testing, we help you make faster, more informed development decisions and comply with evolving global regulations of genetically engineered crops.
When you need solid science and investigative engineering to address product failures, inform legal strategy, protect intellectual property or address product liability disputes,…
When you need solid science and investigative engineering to address product failures, inform legal strategy, protect intellectual property or address product liability disputes, turn to EAG. We’ve provided technical consulting, analysis and expert testimony for hundreds of cases involving the aerospace, transportation, medical device, electronics, industrial and consumer product industries. Our team of experts understands the legal process and your need for responsiveness, effective communication, scientifically defensible opinion and confidentiality. From professional consulting to data review to trial preparation and expert witness testimony, ask EAG.
Using an array of advanced separation techniques and innovative technology, we conduct highly precise analytical chromatography for various industries. Whether you want a closer…
Using an array of advanced separation techniques and innovative technology, we conduct highly precise analytical chromatography for various industries. Whether you want a closer look at the purity of your pharmaceutical or need to better understand an agrochemical’s components, EAG has the expertise to separate and evaluate any compound.
Need to evaluate the molecular structure of a compound or identify its origins? EAG knows how. With state-of-the-art tools, we can separate, vaporize and ionize the atoms and…
Need to evaluate the molecular structure of a compound or identify its origins? EAG knows how. With state-of-the-art tools, we can separate, vaporize and ionize the atoms and molecules in almost any pure or complex material to detect and obtain mass spectra of the components. We rely on decades of experience in mass spectrometry to provide our clients with precise analyses and the best detection limits.
EAG is a world leader in high-resolution imaging down to the atomic level. We offer unmatched analytical know-how, generating extremely detailed surface and near surface images…
EAG is a world leader in high-resolution imaging down to the atomic level. We offer unmatched analytical know-how, generating extremely detailed surface and near surface images for various industries, from consumer electronics to nanotechnology. Using state-of-the-art equipment and innovative techniques, we conduct expert imaging to aid in failure analysis, dimensional analysis, process characterization, particle identification and more. If you want to investigate a material with angstrom scale resolution, you can count on EAG to get the job done quickly and precisely.
EAG offers a vast array of spectroscopic techniques to clients in various industries, from defense contractors to technology pioneers. We combine unparalleled expertise and…
EAG offers a vast array of spectroscopic techniques to clients in various industries, from defense contractors to technology pioneers. We combine unparalleled expertise and methodology with cutting-edge technology to analyze your organic, inorganic, metallic and composite materials for identification, compositional, structural and contaminant information. Whether you need expert spectroscopic analysis to improve your production process or to surmount a technical challenge, EAG is up to the task.
Need to identify your unique material? Want to analyze the thermal properties of a sample, or measure the success of a process step? If it has to be done quickly and it has to be…
Need to identify your unique material? Want to analyze the thermal properties of a sample, or measure the success of a process step? If it has to be done quickly and it has to be done right, you can count on EAG. We offer a range of adaptable techniques and innovative methods to evaluate the physical and chemical characteristics of any compound. Our highly precise testing and analytical services will improve your production process, expedite R&D and help you conquer any technical challenge.
One of the most respected names in contract research and testing, EAG Laboratories is a global scientific services company operating at the intersection of science, technology and…
One of the most respected names in contract research and testing, EAG Laboratories is a global scientific services company operating at the intersection of science, technology and business. The scientists and engineers of EAG apply multi-disciplinary expertise, advanced analytical techniques and “we know how” resolve to answer complex questions that drive commerce around the world.
Science and technology transcend industry boundaries, and so does demand for EAG’s expertise. We partner with companies across a broad spectrum of high-tech, high-impact and…
Science and technology transcend industry boundaries, and so does demand for EAG’s expertise. We partner with companies across a broad spectrum of high-tech, high-impact and highly regulated industries. We help our customers innovate new and improved products, investigate manufacturing problems, perform advanced analyses to determine safety, efficacy and regulatory compliance, and protect their brands.
EAG’s corporate culture is firmly rooted in four guiding principles: “foster a growth mindset,” “find a better way,” “earn more loyal customers,” and “win…
EAG’s corporate culture is firmly rooted in four guiding principles: “foster a growth mindset,” “find a better way,” “earn more loyal customers,” and “win together.” Across all of our 20+ locations, you will find a true passion for science and the power of science to improve the world we live in. Hear what some of our ~1200 scientists, engineers and support personnel say about what it means to be part of EAG Laboratories.
EAG is growing, and we are always looking for talented, problem-solving oriented individuals to join our company. If you have a “we know how” spirit, we want to hear from you.…
EAG is growing, and we are always looking for talented, problem-solving oriented individuals to join our company. If you have a “we know how” spirit, we want to hear from you. Browse current openings now, and re-visit our careers page often.
Validation of expressed proteins in genetically modified organisms (GMO) by enzyme linked immunosorbent assay (ELISA) should follow established bioanalytical procedures. Validation of the analytical method should be subjected to the following experimental checks in the appropriate bio-matrix to ensure it is suitable for its intended use: accuracy, precision, specificity, sensitivity, reproducibility and stability. Validation relies on analysis of reference materials or other suitable plant control material for use as quality control (QC) standards and calibration curve standards. Since well-characterized reference materials are not always available, best efforts are needed to create suitable control materials to support method validation and subsequent field testing. Quality controls are prepared in triplicate at known concentrations (low, mid and high) and calibration curve standards prepared in duplicate at a minimum of six non-zero calibrator concentrations spanning the intended range of analysis. Due to the inherent non-linear behavior of immunoassays, a four or five-parameter logistic model is used with anchoring points at the asymptotic high and low-concentrations. Intra-assay and Inter-assay precision and accuracy are evaluated using three sets of QC samples prepared in the appropriate bio-matrix. The limit of detection (LOD) are calculated from a standard curve using the standard deviation () derived from the absorbance values for the lowest concentration value established for range. Range is determined using results generated from interand intra-assay precision and accuracy. Specificity is evaluated using positive and negative controls prepared in triplicate. Present endogenous compounds that may interfere with the ELISA method are examined in multiple sources of the bio-matrix. Standard stability is assessed in both stock dilution preparations as well in biomatrix for appropriate period of time and condition. To support subsequent routine testing, frozen stability is assessed by analysis of QC samples subjected to three freeze-thaw cycles as well as long term freezer stability for a suitable period of time. Generally accepted acceptance criteria and testing procedures for ELISA methods are described in this presentation.
Provide practical guidance on conduct of method validation studies for ELISA methods in support of expressed proteins in GMO plant products.
Well established validation guidelines for bioanalytical methods ranging from LC-MS/MS to Immunoassays, to include ELISA, exist in support of preclinical GLP studies for pharmaceuticals. In this presentation we will describe the use of these established procedures for method validation and subsequent bioanalytical testing of expressed proteins in GMOs using ELISA methods.
Principle of the ELISA ECL Method: Though many ELISA formats exist for quantitation of proteins in complex bio-matrices, in this presentation a sandwich ELISA using electrochemiluminescene (ECL) detection is used as a model method for description of validation procedures though other ELISA detection methods such as horse radish peroxidase (HRP) reporting methods are equivalent. The assays employ a sandwich immunoassay format where capture antibodies are coated on the bottom of the wells of a specialized ECL compatible 96-well plate. The sample and a solution containing the labeled detection antibody, an anti- GMO protein antibody labeled with a Meso Scale Discovery (MSD) SULFO-TAG™ containing an electrochemiluminescent Ru2+ compound, are incubated over a selected period of time. The GMO protein of interest in the prepared plant tissue sample binds to capture antibody immobilized on the working electrode surface followed by recruitment of the labeled detection antibody by the bound analyte to complete the sandwich. An MSD read buer that provides the appropriate chemical environment for electrochemiluminescence is added and the plate is then loaded into an MSD SECTOR® instrument for analysis. A voltage is applied to the plate electrodes causing the labels bound to the electrode surface to emit light. The instrument measured intensity of emitted light to provide a quantitative measure of GMO protein present in the sample. Quality Control Sample concentrations are extrapolated from a standard curve prepared in the appropriate bio-matrix using puried GMO protein as the reference standard.
Figure 1. Graimetric approach for batch production of QC standard (Low, Mid and High)
GMO Reference Materials: Conduct of validation and subsequent eld sample testing require use of reference materials containing a known amount of GMO expressed protein of interest in an appropriate plant tissue bio-matrix. This reference material is needed to produce two independent standards typically needed for ELISA methods. First, calibration standards are needed to generate the non-linear curve for quantitation of all QCs and field samples. This requires a minimum of six calibration points with anchor points just outside the lower and upper limits of the curve. Calibration standards are typically prepared fresh on the day of analysis in duplicate.
They should range from blank matrix to the matrix containing known amounts of the GMO protein of interest from just below the lower level of quantitation (LLOQ) to the upper level of quantitation (ULOQ) for a minimum of 6 intermediate concentrations with anchor points just outside the calibration lower and upper range of the method. Second, QC standards are typically prepared well ahead of time and stored frozen until needed for analysis. They should be made at low (~3 x the LLOQ), mid and high (ULOQ) concentration in triplicate within the range of the intended method. Sufficient amounts of QC standards are required for multiple days of analysis. Once produced they should be characterized and shown to be stable upon long term storage under the appropriate conditions. Several approaches are possible for generation and characterization of such reference materials as shown below:
Purchase of commercial reference materials when available.
For QC samples, GMO tissue containing protein at well established expression levels may be useful. However, likely not appropriate for use as daily calibration standards.
If commercial reference materials are not available, creation of reference materials could be performed in a number of ways. It is typical practice to prepare calibration curve standards for each day of analysis and independently of QC samples due to differences in concentration and range. The two approaches to product both QC and daily calibration standards are as follows:
a. Creation of GMO reference materials by gravimetrically mixing ground GMO materials of known amount with non- GMO materials, preferably using the same parent plant strain as the GMO variant as depicted in Figure 1. Such materials should be prepared at varying amounts of the expressed protein in the same plant tissue matrix for use as QC standards. This approach may not be advantageous for generation of daily calibration standards due to the manually intensive nature of the process and the large number of concentrations levels needed for calibration standards.
Figure 2. Wet addition for batch production of QC standards
b. Creation of GMO reference materials by spiking in known amounts of purified GMO protein solutions into non-GMO plant tissue of the same parent strain as the recombinant GMO. This could be achieved in several ways:
i. Preparation of large amounts of ground non-GMO plant tissue spiked with the GMO protein solution in a suitable buffer solution so that the material can be well mixed to form a homogeneous spiked QC material at low, mid and high concentrations (Figure 2). Then dry the material by lyophilization and aliquot into small reference vials for subsequent characterization and testing. To ensure the intended concentration and uniformity are satisfactory, 5 to 10% of the aliquots should be tested for protein concentration and content uniformity under a priori acceptance criteria prior to use.
• Advantage: large scale preparations of QC standards would be simplied and should provide a homogeneous standard prepared under gentle conditions.
• Disadvantage: very manually intensive procedures for preparation of calibration standards which are typically prepared daily and at more concentration levels than QCs.
ii. Overcoming this obstacle for creation of daily calibration standards may involve wet spike addition of non- GMO ground tissue with protein solutions of known concentration in an extraction buffer during sample preparation just prior to analysis (Figure 3). Commonly, GMO plant materials are extracted using finely ground plant tissue with an ELISA compatible extraction buffer. Following extraction, the materials are centrifuged to remove particulates prior to ELISA analysis. Test and QC samples are extracted in the same manner but using a protein free extraction buffer.
Figure 3. Production of daily QC standards
• Advantage: an easy approach for preparation of daily calibration standards. Therefore one could prepare this extraction buffer with known amounts of purified GMO protein for preparation of daily calibration standards in non GMO ground plant tissue.
Regardless of the approach for obtaining reference materials it is important to ensure that the concentration of the GMO protein of interest is known, the appropriate plant tissue matrix is used and the reference materials are characterized. Sufficient quantity of such reference materials are needed to support not only validation but subsequent field testing. Lastly, the stability profile of such reference materials needs to be understood to ensure subsequent field testing results are accurate, precise and reproducible over extended periods of time.
Validation Procedures: Method validation consists of several controlled experiments to ensure the method is suitable for its intended use in the appropriate plant bio-matrix. The validation experiments are designed to ensure the method is accurate, precise (intra and inter), specific, sensitive, reproducible and stabile within the intended range of the method. All validation work should be conducted under a formal validation protocol and any changes documented as protocol amendments. Validation experiments should be addressed versus a priori approved acceptance criteria. In Table 1 a listing of such validation tests with typical acceptance criteria are provided.
Selectivity/Specificity: Selectivity/Specificity should be evaluated for the GMO using multiple sources of the GMO bio-matrix. Samples of GMO bio-matrix from six to 12 different individual sources unfortified and fortified with the Reference Standard at the LLOQ and ULOQ should be evaluated. If non- GMO ground plant tissue is not available and only GMO plant tissue is used then evaluation of endogenous levels of GMO protein should be evaluated in unfortified samples. Fortified samples are also to be evaluated for Inter- and intra-run Accuracy, Precision and Total Error. Of the lots evaluated, at least 2/3 of those fortified with Reference Standard should be within 75-125% Recovery Mean of the nominal concentration with a CV 25%. Inter-run data should be 75-125% Recovery Mean with CV 25% and the Total Error should be 40%.
Accuracy and Precision for Calibration Standards: Accuracy and Precision for calibration standards should be evaluated for the GMO protein of interest using the appropriate plant biomatrix. Calibration standards, ranging from the LLOQ to ULOQ to include matrix blanks, are typically prepared fresh on the day of analysis by fortifying the plant bio-matrix with purified protein. Each calibrator is to be run in duplicate wells and analyzed for % Recovery Mean (% RM) and the coefficient of variation (% CV) using mean back-calculated concentrations. A four or fiveparameter curve regression model is typically used to fit the calibrators to a standard curve.
Accuracy and Precision for calibration standards should be evaluated. The Coefficient of Determination (R2) for the nonlinear calibration curve should be >0.980. The % Recovery Mean (% RM) and % CV for 75% of non-zero calibrators should be 80- 120% Recovery Mean (75-125% Recovery Mean at LLOQ) and 20% CV (25% CV at LLOQ) for each plate.
Determination of 214:280 nm Ratio: Accuracy and Precision for QC samples are to be evaluated for the GMO protein in the plant tissue matrix. QC samples at the QC-H, QC-M, and QC-L concentrations are to be prepared fresh on the day of analysis by fortifying plant tissue matrix with the GMO protein. Each QC sample is run in duplicate wells and analyzed for % Recovery Mean (% RM) and the coefficient of variation (% CV) using mean back-calculated concentrations. Accuracy and Precision for QC samples are to be evaluated by determination of the % Recovery Mean and % CV. Typical acceptance criteria (Table 1) indicate 2/3 of the QC samples are required to be 80-120% Recovery Mean and 20% CV. Inter-run data are typically required to be 80-120% Recovery Mean with CV 20% and the Total Error was required to be 30%. Inter day analysis of the QC samples should indicated that the Inter-run total error data are within the acceptable criteria (Table 1).
Table 1. Representative validation tests with acceptance criteria for an ELISA method
Stability: The analyte is considered stable if the mean Recovery Mean is within 80-120% from theoretical and CV 20%.
Bench Top Stability: Bench Top Stability of the spiked QCs should be evaluated with two concentration levels (QC-H and QC-L) in triplicate. Bench top stability should be assayed after storing for approximately 12- to 18-hours on the bench top under conditions stipulated in the sample handling in the method or cold using cold packs or wet ice. Desired results should indicate that the test material is stable during the test period under the appropriate conditions. Mean recovery should be within 80-120% of the theoretical concentration and CV 20%.
Freeze/Thaw Stability: Freeze-thaw stability of the Fortified assay QC samples should be evaluated at a minimum of two concentration levels (QC-H and QC-L) in triplicate. Freeze-thaw stability samples should be subjected to minimum of three freezethaw cycles. There should be approximately a 24-hour interval or longer at the first freezing, and at least 12-hour intervals between freezing cycles thereafter. Thawing cycles should last a minimum of 2 hours on wet ice or other appropriate condition. Desirable results should indicate that the test material is stable through two or more freeze-thaw cycles as demonstrated by recovery within the required 80-120% of the theoretical concentration and 20% CV.
Freezer Storage Stability: The long term storage stability of the test material should be evaluated with fortified QC samples at a minimum of two concentration levels (QC-H and QC-L) after storage at ~-60°C or at ~-20°C. The long-term freezer storage stability should be tested in triplicate for both of these storage conditions for 0, 0.5, 1, 2, 3, 6 and 12 months (or more). Desired results should indicate that the test material was stable minimally for 1 month and optimally at 12 months when stored under the appropriate frozen condition. The target storage condition for Lyophilized QCs may be refrigerated. Freezer stability will be demonstrated by recovery within the required 80-120% from theoretical concentration and 20% CV.
Proper validation of an ELISA method for analysis of expressed proteins in plant GMOs ensures the results from subsequent field testing are of high quality. Ensuring the method is suitable for its intended use by demonstrating the method is accurate, precise, specific, sensitive, reproducible and stable provides a strong foundation for subsequent field testing and regulatory submissions. In comparison to most bioanalytical procedures, analysis of transgenic proteins in plant tissue does present some technical obstacles. First, reference materials are not commonly available for non-European GMO products. Therefore, production of the 2 primary standards used in GLP compliant bioanalytical methods, calibration standards and quality control (QC) standards, are crucial. Two proposed procedures are presented: mixtures of GMO and non-GMO plant matrices by gravimetric means or spike addition of plant matrix material with purified protein solutions. The later, wet spike addition can be performed in two different ways. For production of large batches of QC standards, non-GMO matrix can be fortified by wet addition of purified protein solutions, mixed then lyophilized in order to produce homogeneous QC materials. Such QC batches would require testing to ensure they are accurate, homogeneous and stable upon long term frozen storage prior to routine use. Calibration standards could be produced daily also by wet addition, but by means of an extraction buffer, allowing for rapid and ease of production needed for daily use. Last, validation procedures are presented in detail to allow the reader a framework they could use for future method validation and subsequent GLP compliant analysis by ELISA.